The Jones Eye Clinic Research Department was established to ensure high quality clinical trials in vision research. Clinical research is an important part of our practice as it enables our patients to access new technologies that may otherwise be unavailable and helps gain FDA approval of such technologies for general use. Our commitment involves conducting medical research with the goal of helping patients obtain a higher quality of vision and better manage eye disease.
A clinical trial is a research study conducted according to a protocol to see if a new drug, device, or procedure is safe and effective for people to use and to compare existing treatments to determine which is better. Volunteering for a clinical trial is a personal choice and whether or not you participate should be made only after carefully considering the risks and benefits.
The members of our research team are as follows:
- Jason Jones, MD, our Principal Investigator
- Yian Jones, MD, Sub-Investigator
- Wing Hsieh, OD, Sub-Investigator
- Jacob Woldt, OD, Sub-Investigator
- Lisa Atkinson, COT, Clinical Research Coordinator
Jones Eye Clinic is currently enrolling patients in the following FDA sponsored clinical trials:
Study 1
TRAVOPROST INTRAOCULAR IMPLANT CLINICAL STUDY
TRAVOPROST INTRAOCULAR IMPLANT CLINICAL STUDY
If you’ve been told by your doctor that you have glaucoma or high eye pressure, you may be able to participate in a clinical study of the Travoprost Intraocular Implant.
To qualify, you must:
- Be 18 years of age or older
- Meet all other study-related criteria
Participants receive:
- Thorough screening evaluation of your eye health
- Follow-up visits for up to three years
- Reimbursement for costs related to time and travel
HOW YOU CAN PARTICIPATE
An intraocular implant containing a slowly releasing travoprost medication will be placed in your eye through a tiny opening in the cornea.
Ask your eye doctor if you are a candidate for the Travoprost Intraocular Implant clinical study.
To learn more about the Travoprost Intraocular Implant clinical study visit www.GlaukosClinicalTrials.com
Caution: New Drug—Limited by Federal (or United States) law to investigational use.
Version 01MAR2018 20180735 #17963175.0
Contact our research coordinator for additional information about any of our clinical trials.
Lisa Atkinson, COT, Research Coordinator
1-800-334-2015 ext. 132
You may find more information on clinical trials by visiting www.clinicaltrials.gov
